Sustained silver-releasing dressing in the treatment of diabetic foot ulcers.
This study investigated the clinical performance and safety of a sustained silver-releasing foam dressing, Contreet Foam, in the treatment of diabetic foot ulcers. Twenty-seven patients with diabetic foot ulcers of grade I or II (Wagner's classification) were followed for six weeks: one week run-in using Biatain dressings, four weeks' treatment with Contreet dressings. Four ulcers healed during the four-week treatment with Contreet 56% in average. Contreet Foam showed good exudate management properties and was considered easy to use. Only two infections occurred showed that all six of the non-study ulcers developed an infection during the study. All ulcers (study ulcers as well as non-study ulcers) were treated according to good practice of diabetic wound care. There were no directions for the treatment of secondary wounds. No device-related adverse events were observed. This study demonstrated that Contreet Foam is safe and easy to use and effectively supports healing and good wound progress of diabetic foot ulcers.
Rayman
G
G
Diabetic Foot Research Office, The Ipswich Hospital NHS Trust, Ipswich UK.
Rayman
A
A
Baker
N R
NR
Jurgeviciene
N
N
Dargis
V
V
Sulcaite
R
R
Pantelejeva
O
O
Harding
K G
KG
Price
P
P
Lohmann
M
M
Thomsen
J K
JK
Gad
P
P
Gottrup
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D047070:Bandages, Hydrocolloid; D003692:Delayed-Action Preparations; D017719:Diabetic Foot / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012834:Silver / Q000008:administration & dosage* / Q000032:analysis; D014945:Wound Healing
D003692:Delayed-Action Preparations; D012834:Silver